你即將離開本站

並前往https://www.kireports.org/article/S2468-0249(21)01015-9/fulltext

30 mL/min/1.73 m2: FINDINGS FROM THE DAPA-CKD TRIAL

The DAPA-CKD trial demonstrated that the sodium glucose co-transporter 2 (SGLT2) inhibitor dapagliflozin significantly reduced the risk of kidney failure, ...

確定！ 回上一頁

查詢 「DAPA-CKD trial」的人也找了：

  1. dapa-ckd trial ppt
    2.
  2. Dapagliflozin hemodialysis
    3.
  3. EMPA CKD
    4.
  4. dapa ckd中文
    5.
  5. CREDENCE trial
    6.
  6. Dapa ckd trial wiki
    7.
  7. Empagliflozin CKD
    8.
  8. DECLARE-TIMI 58
    9.